Antibodies, vaccines and adjuvants - Pharmaceutical Biotechnology: Concepts and Aapplications - page 420

Edelman, R. 2002. The development and use of vaccine adjuvants. Molecular Biotechnology 21 (2), 129-148.
Francis, J. and Larche, M. 2005. Peptide-based vaccination: where do we stand? Current Opinion in Allergy and
Clinical Immunology 5 (6), 537-543.
Hilton, L.S., Bean, A.G., and Lowenthal, J.W. 2002. The emerging role of avian cytokines as immunotherapeutics
and vaccine adjuvants. Veterinary Immunology and Immunopathology 85 (3-4), 119-128.
Jackson, M. and Myers, A. 2005. Vaccines in the pipeline. Pediatric Emergency Care 21 (11), 777-783.
Lemon, S. and Thomas, D. 1997. Drug therapy - vaccines to prevent viral hepatitis. New England Journal of
Medicine 336 (3), 196-204.
Lollini P.L., Cavallo, F., Nanni, P., and Forni, G. 2006. Vaccines for tumour prevention. Nature Reviews Cancer
6 (3), 204-216.
Mason, H.S., Warzecha, H., Mor, T., and Arntzen, C.J. 2002. Edible plant vaccines: applications for prophylactic
and therapeutic molecular medicine. Trends in Molecular Medicine 8 (7), 324-329.
Petrovsky, N. and Aguilar, J. 2004. Vaccine adjuvants: current state and future trends. Immunology and Cell
Biology 82 (5), 488-496.
Plotkin, S. 2002. Vaccines in the 21st century. Hybridoma and Hybridomics 21 (2), 135-145.
Poland, G.A., Murray, D., and Bonilla-Guerrero, R. 2002. Science, medicine and the future: new vaccine devel-
opment. British Medical Journal 324 (7349), 1315-1319.
Puls, R. and Emery, S. 2006. Therapeutic vaccination against HIV: current progress and future possibilities.
Clinical Science 110 (1), 59-71.
Sela, M., Arnon, R., and Schechter, B. 2002. Therapeutic vaccines: realities of today and hopes for the future.
Drug Discovery Today 7 (12), 664- 673.
Shams, H. 2005. Recent developments in veterinary vaccinology. Veterinary Journal 170 (3), 289-299.
Singh, M. and O'Hagan, D. 2002. Recent advances in vaccine adjuvants. Pharmaceutical Research 19 (6), 715-728.
Spearman, P. 2006. Current progress in the development of HIV vaccines. Current Pharmaceutical Design
12 (9), 1147-1167.
Stevceva, L. and Ferrari, M 2005. Mucosal adjuvants. Current Pharmaceutical Design 11 (6), 801-811.
Taylor, D. 2006. Obstacles and advances in SARS vaccine development. Vaccine 24 (7), 863-871.
Vajdy, M. and Singh, M. 2005. The role of adjuvants in the development of mucosal vaccines. Expert Opinion on
Biological Therapy 5 (7), 953-965.
Yokoyama, N., Maeda, K., and Mikami, T. 1997. Recombinant viral vector vaccines for veterinary use. Journal
of Veterinary Medical Science 59 (5), 311-322.